Alopecia areata developing paralell to improvement of psoriasis during ustekinumab therapy

Journal of Dermatological Case Reports

Volumn 4, Issue 1, 2010, Pages 15-17

  Słowińska, Monika ^a   Kardynal, Agnieszka ^a   Warszawik, Olga ^a   Czuwara, Joanna ^a   Rudnicka, Lidia ^a,b,c  

^a Dept Dermatology CSK MSWiA ^*  (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c POLISH ACADEMY OF SCIENCES   (Poland)

Author keywords

Biological drugs; Confocal reflectance microscopy; Dermoscopy; Interleukin 23; Psoriasis; Renb k phenomenon; Trichoscopy

Indexed keywords

ADALIMUMAB; ALEFACEPT; ANTIPSORIASIS AGENT; CYTOKINE; EFALIZUMAB; ETANERCEPT; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; INTERLEUKIN 12; MONOCLONAL ANTIBODY; NEW DRUG; USTEKINUMAB;

ADULT; ALOPECIA; ALOPECIA AREATA; ARTICLE; CASE REPORT; CONFOCAL MICROSCOPY; DISEASE ACTIVITY; DISEASE SEVERITY; EMOTIONAL STRESS; HAIR GROWTH; HAIR LOSS; HUMAN; MALE; PATHOGENESIS; PSORIASIS; PSORIASIS ACTIVITY AND SEVERITY INDEX; QUALITY OF LIFE; REPEATED DRUG DOSE; SCALP; SCORING SYSTEM; TOOTH INFECTION; TREATMENT OUTCOME;

EID: 77956289560     PISSN: None     EISSN: 18987249     Source Type: Journal    
DOI: 10.3315/jdcr.2010.1041     Document Type: Article

References (10)

1. Criado PR, Valente NY, Michalany NS, Martins JE, Romiti R, Aoki V, Vasconcellos C. An unusual association between scalp psoriasis and ophiasic alopecia areata: the Renbok phenomenon. Clin Exp Dermatol. 2007; 32: 320-1.
2. Kos L, Conlon J. An update on alopecia areata. Curr Opin Pediatr. 2009; 21: 475-80.
3. Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, Gottlieb AB, Koo JY, Lebwohl M, Lim HW, Van Voorhees AS, Beutner KR, Bhushan R. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. J Am Acad Dermatol. 2009; 61: 451-85.
4. Tosti A, Pazzaglia M, Starace M, Bellavista S, Vincenzi C, Tonelli G.Alopecia areata during treatment with biologic agents. Arch Dermatol. 2006; 142: 1653-4.
5. Gee K, Guzzo C, Che Mat NF, Ma W, Kumar A. The IL-12 family of cytokines in infection, inflammation and autoimmune disorders. Inflamm Allergy Drug Targets. 2009; 8: 40-52.
6. Barahmani N, Lopez A, Babu D, Hernandez M, Donely SE, Duvic M. Serum T helper 1 cytokine levels are greater in patients with alopecia areata regardless of severity or atopy. Clin Exp Dermatol. 2009 Oct 23. [Epub ahead of print]
7. Tan ZY, Bealgey KW, Fang Y, Gong YM, Bao S. Interleukin-23: immunological roles and clinical implications. Int J Biochem Cell Biol. 2009; 41: 733-5.
8. Elliott M, Benson J, Blank M, Brodmerkel C, Baker D, Sharples KR, Szapary P. Ustekinumab: lessons learned from targeting interleukin-12/23p40 in immune-mediated diseases. Ann N Y Acad Sci. 2009; 1182: 97-110.
9. Inui S, Nakajima T, Itami S. Coudability hairs: a revisited sign of alopecia areata assessed by trichoscopy. Clin Exp Dermatol. 2009 Oct 23. [Epub ahead of print]
10. Rudnicka L, Olszewska M, Rakowska A. In vivo reflectance confocal microscopy: usefulness for diagnosing hair diseases. J Dermatol Case Rep. 2008; 4: 55-59.